Global Genetic Toxicology Testing Market Revenue Grows at a CAGR of 11.28%

Straits Research released its highly anticipated report, “Global Genetic Toxicology Testing Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 1.57 billion in 2025 and is anticipated to grow to USD 4.10 billion by 2034, growing at a CAGR of 11.28% from 2026-2034.

Market Dynamics

The genetic toxicology testing market is driven by rising emphasis on early safety evaluation across drug development, chemical manufacturing, and consumer product formulation, as companies increasingly prioritize structured testing to detect DNA damage, chromosomal alterations, and mutation risks during preclinical stages. The market faces restraint due to variability in assay interpretation, differences in laboratory practices across regions, and limited alignment in global protocols, which create challenges for organizations seeking uniform datasets for regulatory submissions. Despite these limitations, the market presents a strong opportunity through growing adoption of computational toxicology and AI-based prediction platforms that enable faster screening of large chemical libraries, support mechanism-based assessments, and complement laboratory testing to enhance overall genotoxicity evaluation strategies.

Market Highlights

• Product: Based on Product, the services segment dominated the market with a revenue share of 47.83% in 2025.
• Type: Based on Type, the in vivo segment registered the fastest growth with 12.43% during the forecast period.
• Assay: Based on the Assay, the comet assay segment dominated the market with 41.23% share in 2025.
• Application: Based on Application, the pharmaceutical and biotechnology segment dominated the market with a 49.53% share in 2025.
• Regional Insights: North America held a dominant share of the global market, accounting for 39.13% share in 2025.

Market Segments

1. By Product (2026-2034)
   1. Reagents & Consumables
   2. Assays Kit
   3. Services
2. By Type (2026-2034)
   1. In Vitro
   2. In Vivo
3. By Assay (2026-2034)
   1. Comet Assay
   2. Micronucleus Assay
   3. Chromosomal Aberration Test
   4. Genetic Mutation Test
   5. Others
4. By Application (2026-2034)
   1. Pharmaceutical & Biotechnology
   2. Food Industry
   3. Cosmetics Industry
   4. Other